A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer Chemotherapy and Pharmacology

Topics

Medicine

Internal Medicine

Gastroenterology

Molecular Biology

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1007/s00280-012-2045-1